Your search history is turned on.
Date: February 10, 2016 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 5, 2016 Tribute Pharmaceuticals Canada Inc. (Exact name of registrant as specified in its charter) 151 ...
Date: February 5, 2016 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
As filed with the Securities and Exchange Commission on February 4, 2016 Registration No. 333-187927 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRIBUTE PHARMACEUTICALS CANADA INC. (Exact name of registrant as sp...
As filed with the Securities and Exchange Commission on February 4, 2016 Registration No. 333-170459 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRIBUTE PHARMACEUTICALS CANADA INC. (Exact name of registrant as spe...
As filed with the Securities and Exchange Commission on February 4, 2016 Registration No. 333-197817 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRIBUTE PHARMACEUTICALS CANADA INC. (Exact name of registrant as sp...
Date: February 2, 2016 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - NOTICE TO READER.docx NOTICE TO READER At the request of the Ontario Securities Commission, Tribute Pharmaceuticals Canada Inc. is filing the attached financial statements to provide a total of nine months (six months herein and three months in the previously filed financial statements for the year ended December 31, 2014) of audited financial informatio...
Date: February 1, 2016 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 For the quarterly period ended: June 30, 2015 Or For the transition period from: _____________ to _____________ TRIBUTE PHARMACEUTICALS CANADA INC. (Exact name of registrant as specified in its charter) ...
Date: January 29, 2016 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
Microsoft Word - BAR - Novartis v.2.doc FORM 51-102F4 BUSINESS ACQUISITION REPORT TRIBUTE PHARMACEUTICALS CANADA INC. (the "Company" or "Tribute") ITEM 1 IDENTITY OF COMPANY 1.1 NAME AND ADDRESS OF COMPANY Tribute Pharmaceuticals Canada Inc. 544 Egerton Street London, Ontario N5W 3Z8 1.2 EXECUTIVE OFFICER For additional information regarding any inform...
Date: January 21, 2016 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 21, 2016 Tribute Pharmaceuticals Canada Inc. (Exact name of registrant as specified in its charter) ...
Date: January 11, 2016 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Saskatchewan
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 11, 2016 Tribute Pharmaceuticals Canada Inc. (Exact name of registrant as specified in its charter) ...